A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo

Leukemia. 2017 Oct;31(10):2278. doi: 10.1038/leu.2017.219. Epub 2017 Jul 28.

Authors

S Hipp, Y-T Tai, D Blanset, P Deegen, J Wahl, O Thomas, B Rattel, P J Adam, K C Anderson, M Friedrich

PMID: 28751764
DOI: 10.1038/leu.2017.219

Abstract

This corrects the article DOI: 10.1038/leu.2016.388.

Publication types

Published Erratum